ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,173Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 546

$580K Total Retail Price of All Prescriptions

Rank: 38 out of 546

402 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 402 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

16% of this provider’s 402 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

3% of this provider’s 7,853 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
ATENOLOL 472 307 1 12
LEVOTHYROXINE SODIUM 448 349 2 3
HYDROCHLOROTHIAZIDE 377 331 3 7
SIMVASTATIN 358 267 4 2
LISINOPRIL 341 274 5 1
HYDROCODONE-ACETAMINOPHEN 325 171 S3 6 8
FUROSEMIDE 310 254 7 5
LOSARTAN POTASSIUM 281 234 8 24
AMLODIPINE BESYLATE 280 255 9 9
METOPROLOL TARTRATE 267 245 10 6
METFORMIN HCL 248 193 11 10
OMEPRAZOLE 242 161 12 4
LOVASTATIN 239 197 13 22
CITALOPRAM HBR 237 153 14 21
METOPROLOL SUCCINATE 172 143 15 17
ISOSORBIDE MONONITRATE ER 158 131 16 32
GLYBURIDE 148 115 R 17 45
PRAVASTATIN SODIUM 145 99 18 33
ATORVASTATIN CALCIUM 143 110 19 11
PANTOPRAZOLE SODIUM 139 81 20 18
WARFARIN SODIUM 139 107 20 13
POTASSIUM CHLORIDE 139 78 20 30
SERTRALINE HCL 136 78 23 14
RANITIDINE HCL 131 77 24 23
ZOLPIDEM TARTRATE 129 73 25 26
TERAZOSIN HCL 118 117 26 83
TRAZODONE HCL 116 71 27 25
CYCLOBENZAPRINE HCL 116 67 R 27 34
TRAMADOL HCL 114 67 29 19
OXYCODONE HCL 110 25 S2 30 15
AMITRIPTYLINE HCL 108 64 R 31 48
OXYCONTIN 98 18 S2 32 75
DIFLUNISAL 95 57 33 210
GABAPENTIN 89 47 34 16
COMBIVENT 83 53 35 71
KLOR-CON M20 74 59 36 57
DILTIAZEM 24HR CD 72 63 37 91
INDAPAMIDE 72 60 37 218
PREDNISONE 71 62 39 29
SPIRONOLACTONE 70 39 40 82
FLOVENT HFA 67 50 41 139
PROAIR HFA 67 41 41 27
KLOR-CON M10 63 63 43 118
TAMSULOSIN HCL 63 57 43 35
ALENDRONATE SODIUM 60 50 45 38
CRESTOR 55 40 46 36
CARBIDOPA-LEVODOPA 54 42 47 76
FENOFIBRATE 53 31 48 87
NEXIUM 52 43 49 52
ALLOPURINOL 51 40 50 41
INSULIN SYRINGE 51 33 50 85
BUPROPION XL 50 0 52 93
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 26, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.